Jaguar Gene Ther­a­py spins out man­u­fac­tur­ing with Deer­field, ARCH sup­port

Jaguar Gene Ther­a­py will spin out its chem­istry, man­u­fac­tur­ing and con­trols (CMC) op­er­a­tions and cre­ate a sep­a­rate com­pa­ny called Ad­vanced Med­i­cine Part­ners, with the sup­port of Deer­field, ARCH Ven­ture Part­ners, Nolan Cap­i­tal and oth­ers, it said Wednes­day.

The same in­vestors have backed Jaguar, a pre­clin­i­cal gene ther­a­py biotech based in the Chica­go sub­urbs that was formed by AveX­is vet­er­ans hop­ing to re­peat their Zol­gens­ma suc­cess. Ad­vanced Med­i­cine Part­ners de­clined to dis­close how much fi­nan­cial sup­port it is re­ceiv­ing from the in­vestors. ARCH has backed oth­er man­u­fac­tur­ers like Na­tion­al Re­silience.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER